Zolis .....too long to read your post but let me
Post# of 36536
It's time to produce with with all the hype of leading edge, Merck, Altucell closing, AE37 recruitment. revenue generating acquisitions, AZ revenue, SEC delaying listing...., waiting for better valuation?? , world-class Management. So far money talks BS walks and we continue to walk.
Like I said before I believe in von Hofe/Epivax but forward looking business deals based on past decisions...... questionable at best. Of course if funds show up we have to worry about the investment strategy...........oh yes ......the 2.50 pps turned into a complete miscalculated vision !!! What's next ??
Nasdaq listing and solid institutional support is necessary to be successful but unfortunately most credible institutions conduct due-diligence and decide based on potential - CEO/Management.
Glad you are happy with the progress and continue to support current business decisions and I assume the lucrative CHINA deal !!! I'm all for compensation for hard working people if any results. Stick with the bonus for now until we have a solid stable listing or restrict shares like TC mentioned.
If this company has World class Management and the best vaccine potential we should be able to convince Big Pharma.............maybe even our friends at Merck .....how many people recruited so far ? Last PR I believe was Sept 2019????
https://clinicaltrials.gov/ct2/show/record/NC...amp;rank=1